Vivos Therapeutics, Inc. Proceeds from Long-Term Debt Issued
Vivos Therapeutics, Inc. (VVOS) reported Proceeds from Long-Term Debt Issued of $3.02 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-08-14
- Vivos Therapeutics, Inc. proceeds from issuance of long-term debt for the quarter ending 2026-06-30 was $1.63M.
- Vivos Therapeutics, Inc. proceeds from issuance of long-term debt for the quarter ending 2026-03-31 was $1.40M.
- Vivos Therapeutics, Inc. proceeds from issuance of long-term debt for the quarter ending 2025-12-31 was $1.45M.
- Vivos Therapeutics, Inc. proceeds from issuance of long-term debt for the quarter ending 2025-09-30 was -$417.00K.
- Vivos Therapeutics, Inc. proceeds from issuance of long-term debt for fiscal 2025 was $10.67M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $3.02M 10-Q · filed 2026-08-14 | $4.47M derived: sum of 3 quarters · filed 2026-08-14 | $4.06M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $1.40M 10-Q · filed 2026-05-20 | $2.85M derived: sum of 2 quarters · filed 2026-05-20 | $2.43M derived: sum of 3 quarters · filed 2026-05-20 | |
| 2025-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $1.03M derived: sum of 2 quarters · filed 2026-04-15 | $10.67M 10-K · filed 2026-04-15 | |
| 2025-09-30 | -$417.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $9.22M 10-Q · filed 2025-11-19 | ||
| 2025-06-30 | $9.64M 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |